The Vigabatrin REMS Program is required by the FDA to make certain educated risk-benefit choices prior to initiating therapy, and to make sure proper use vigabatrin while people are treated. It is not feasible for your doctor to know when vision loss will certainly occur.
The most common side effect of SABRIL in youngsters 3 to 16 years is weight gain. With extreme vision loss, you may only be able to see things directly in front of you (often called one-track mind"). You are at risk for vision loss with any kind of amount of SABRIL.
Tell your healthcare provider if you are expectant or mean to get expecting. If vision testing can not be done, your doctor may proceed suggesting SABRIL, but will certainly not be able to expect any vision loss. Your medical care company may quit suggesting SABRIL for you (or your child)if vision examinations are not done consistently.